These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

406 related items for PubMed ID: 15527852

  • 21. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
    Checroune F, Yao XJ, Göttlinger HG, Bergeron D, Cohen EA.
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep 01; 10(1):1-7. PubMed ID: 7648278
    [Abstract] [Full Text] [Related]

  • 22. Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.
    Wu X, Liu H, Xiao H, Kappes JC.
    Virology; 1996 May 01; 219(1):307-13. PubMed ID: 8623547
    [Abstract] [Full Text] [Related]

  • 23. Identification of a key target sequence to block human immunodeficiency virus type 1 replication within the gag-pol transframe domain.
    Sei S, Yang QE, O'Neill D, Yoshimura K, Nagashima K, Mitsuya H.
    J Virol; 2000 May 01; 74(10):4621-33. PubMed ID: 10775598
    [Abstract] [Full Text] [Related]

  • 24. Characterization of human immunodeficiency virus type-1 (HIV-1) particles that express protease-reverse transcriptase fusion proteins.
    Cherry E, Liang C, Rong L, Quan Y, Inouye P, Li X, Morin N, Kotler M, Wainberg MA.
    J Mol Biol; 1998 Nov 20; 284(1):43-56. PubMed ID: 9811541
    [Abstract] [Full Text] [Related]

  • 25. Importance of protease cleavage sites within and flanking human immunodeficiency virus type 1 transframe protein p6* for spatiotemporal regulation of protease activation.
    Ludwig C, Leiherer A, Wagner R.
    J Virol; 2008 May 20; 82(9):4573-84. PubMed ID: 18321978
    [Abstract] [Full Text] [Related]

  • 26. Decreasing the frameshift efficiency translates into an equivalent reduction of the replication of the human immunodeficiency virus type 1.
    Dulude D, Berchiche YA, Gendron K, Brakier-Gingras L, Heveker N.
    Virology; 2006 Feb 05; 345(1):127-36. PubMed ID: 16256163
    [Abstract] [Full Text] [Related]

  • 27. In vivo processing of Pr160gag-pol from human immunodeficiency virus type 1 (HIV) in acutely infected, cultured human T-lymphocytes.
    Lindhofer H, von der Helm K, Nitschko H.
    Virology; 1995 Dec 20; 214(2):624-7. PubMed ID: 8553565
    [Abstract] [Full Text] [Related]

  • 28. Role of capsid sequence and immature nucleocapsid proteins p9 and p15 in Human Immunodeficiency Virus type 1 genomic RNA dimerization.
    Kafaie J, Dolatshahi M, Ajamian L, Song R, Mouland AJ, Rouiller I, Laughrea M.
    Virology; 2009 Mar 01; 385(1):233-44. PubMed ID: 19070880
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Expression and purification of active form of HIV-1 protease from E.coli.
    Wan M, Loh BN.
    Biochem Mol Biol Int; 1995 Apr 01; 35(4):899-912. PubMed ID: 7627139
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Amino acid substitutions at the HIV-1 transframe region significantly impair virus infectivity.
    Yu FH, Huang KJ, Wang CT.
    PLoS One; 2022 Apr 01; 17(1):e0262477. PubMed ID: 35085286
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Hydrophilic peptides derived from the transframe region of Gag-Pol inhibit the HIV-1 protease.
    Louis JM, Dyda F, Nashed NT, Kimmel AR, Davies DR.
    Biochemistry; 1998 Feb 24; 37(8):2105-10. PubMed ID: 9485357
    [Abstract] [Full Text] [Related]

  • 38. Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness?
    de Oliveira T, Engelbrecht S, Janse van Rensburg E, Gordon M, Bishop K, zur Megede J, Barnett SW, Cassol S.
    J Virol; 2003 Sep 24; 77(17):9422-30. PubMed ID: 12915557
    [Abstract] [Full Text] [Related]

  • 39. HIV-1 Vpr-chloramphenicol acetyltransferase fusion proteins: sequence requirement for virion incorporation and analysis of antiviral effect.
    Yao XJ, Kobinger G, Dandache S, Rougeau N, Cohen E.
    Gene Ther; 1999 Sep 24; 6(9):1590-9. PubMed ID: 10490769
    [Abstract] [Full Text] [Related]

  • 40. Strict conservation of the retroviral nucleocapsid protein zinc finger is strongly influenced by its role in viral infection processes: characterization of HIV-1 particles containing mutant nucleocapsid zinc-coordinating sequences.
    Gorelick RJ, Gagliardi TD, Bosche WJ, Wiltrout TA, Coren LV, Chabot DJ, Lifson JD, Henderson LE, Arthur LO.
    Virology; 1999 Mar 30; 256(1):92-104. PubMed ID: 10087230
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.